Addition Of The Parp Inhibitor, Talazoparib, To Gemtuzumab Ozogamicin Significantly Enhances Anti-Leukemic Activity In Human Cd33+Acute Myeloid LeukemiaScott M. Portwood, Marianna C Cantella,Tara L. Cronin,Eunice S. WangBLOOD（2019）引用 7|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
